Skip to main content
. 2021 May 20;62(9):1200–1206. doi: 10.2967/jnumed.120.260687

FIGURE 2.

FIGURE 2.

Timeline of clinical studies of bsAb and streptavidin–biotin pretargeting approaches. Each rectangle refers to a published report, with radionuclide note referring to primary radionuclide used in study. Pretargeting agents used in each report are color coded.